The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 14, 2017
Filed:
Dec. 12, 2014
Applicant:
University of Tsukuba, Tsukuba-shi, Ibaraki, JP;
Inventors:
Hiroshi Nagase, Tsukuba, JP;
Takashi Nagahara, Yokohama, JP;
Assignee:
University of Tsukuba, Tsukuba, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/04 (2006.01); C07D 207/04 (2006.01); C07D 211/16 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 231/14 (2006.01); C07D 233/90 (2006.01); C07D 307/68 (2006.01); C07D 333/38 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01); C07C 311/44 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01); C07D 213/34 (2006.01); C07D 213/61 (2006.01); C07D 213/64 (2006.01); C07D 295/192 (2006.01);
U.S. Cl.
CPC ...
C07D 213/81 (2013.01); C07C 311/21 (2013.01); C07C 311/29 (2013.01); C07C 311/44 (2013.01); C07D 205/04 (2013.01); C07D 207/04 (2013.01); C07D 211/16 (2013.01); C07D 213/34 (2013.01); C07D 213/61 (2013.01); C07D 213/64 (2013.01); C07D 213/82 (2013.01); C07D 231/14 (2013.01); C07D 233/90 (2013.01); C07D 295/192 (2013.01); C07D 307/68 (2013.01); C07D 333/38 (2013.01); C07D 401/12 (2013.01); C07D 409/12 (2013.01);
Abstract
The present invention aims to provide a novel low-molecular-weight compound having an orexin agonist activity, which is expected to be useful as a superior agent for the treatment or prophylaxis of narcolepsy. The present invention provides a compound showing superior orexin agonist activity which is represented by the formula (I) wherein each symbol is as defined in the DESCRIPTION, and a pharmaceutically acceptable acid addition salt thereof, as well as an orexin agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.